Milepæl nået🥇

Vi har udgivet genetiske svar på 20.000 patienter
(ikke prøver som kagen siger)!
Denne enorme team-indsats fra både laboratoriet, kliniske akademikere, funktionsledere, sekretærer og alle andre skal selvfølgelig fejres!

This special edition of #SIUJ features Liquid Biopsy in Genitourinary Malignancies. Read the #GiantsInUrology spotlight on Dr. Alvaro Morales and his perspectives on 50 years of BCG in bladder cancer #OpenAccess #Journal 📜Read the July Issue TODAY: bit.ly/3kfexdV

More fantastic work by Dr Li!

Wanna see something awesome?

Sabrina Ionescu (Sabrina Ionescu) just scored 37 points in the final round of the 3pt contest.

Nobody, including NBA players have ever done that before.

A preprint of our work on tumor-informed ctDNA based MRD surveillance in bladder cancer using Whole genome mutational analysis. Lars Dyrskjøt Sia Viborg Lindskrog Karin Birkenkamp-Demtröder Dept. of Molecular Medicine C2i Genomics

medrxiv.org/search/MEDRXIV…

Methods for tumor informed #cfDNA #ctDNA analysis Iver Nordentoft

Cancer research breakthrough!
🧬Fragmentation patterns in cfDNA can be used to classify #Cancer types.
🧬This could lead to new, more accurate, and cost-effective ways to diagnose and treat cancer. #MedTwitter Hem-Onc Fellows Network Annals of Oncology OncoAlert Misha Beltran Rana McKay…

Highlight: Adaptive Immunity in Genitourinary Cancers

buff.ly/449pcIP

Madhuri Koti Trinity J. Bivalacqua Peter Black Matt Galsky Molly Ingersoll Ashish M. Kamat, MD, MBBS

#MedTwitter #UroSoMe

På Folkemødet #fmdk i går fortalte Claus Lindbjerg Andersen og Lars Dyrskjøt om forskningen i ctDNA guidet kræftbehandling i det nationale samarbejde i ctDNA_DK 🩸🧬

Tak til alle for at møde op og stille gode spørgsmål! 🙌

#ctDNA #CancerResearch #Samarbejdeomkræft

👩‍🎓Julie Rasmussen will defend her Master's thesis on Thu June 22nd 14:30 at MOMA, ground floor auditorium

Karin Birkenkamp-Demtröder Thomas Bjarnsholt

#bladdercancer #microbiome

Researchers at the Crick and King's College London have made key findings about the way cancer interacts with surrounding immune cells. The findings, which could help discover new immunotherapy targets, were published in Genome Medicine

✍️ Hrvoje Misetic Francesca Ciccarelli
ow.ly/FMz250OJVsk

Today we present our recent data on WGS based ctDNA analyses for monitoring response and detection of relapse in bladder cancer at #ASCO23 . Please stop by the poster this morning if you are in Chicago. Iver Nordentoft will guide you through the data and results😊 ctDNA_DK

The arrival of NovaSeq X+ cutting-edge technology marks a significant advancement in our work with whole-genome sequencing in patients.
The video highlights application for children's cancer and showcases the remarkable benefits we anticipate.
linkedin.com/posts/moma-auh…
Mette Christiansen

Aweeeeeeeee this is so beautiful.

twitter.com/kaz22532418/st…

Here is how I have annotated it.
And this was only Figure 1 of the paper. But several other figures raise concerns too.

Can a Urine Test Change the Standard of Care for Bladder Cancer? | Moffitt moffitt.org/endeavor/archi…

In case you missed it: Women are less likely to be credited for their scientific contributions than men. It’s true across multiple fields & at all stages, with important repercussions for career progress. #WomenInSTEM #WomenInMedicine #MedTwitter

nature.com/articles/s4158…

🩸 in your urine is the most common symptom of #BladderCancer . Bladder cancer can be treated effectively if caught early! Have you experienced it? Don’t stay unsure, #GetChecked !
Support@WorldBladderCan Get involved now 👉 worldbladdercancer.org/awareness-mont…

#ISMRC2023 fantastic conference

The #ISMRC2023 took place last week. We had many great talks, discussions and a great time. Thank you all for beeing there.
Looking forward to see you all in Nice 2025!
#LiquidBiopsy #CancerResearch #MRD #biomarkers #Immunotherapy #immunooncology #precisionmedicine